NCT01015157

Brief Summary

Study objectives : Primary endpoint is to a assess the change in blood loss (originating from stapling the stomach) with the use of Seamguard reinforcement Secondary endpoint is to evaluate the difference in leak rate Methods : Prospective. Randomized study. Published data does not allow for clear determination of the number of patients required for the study. Based on our own experience. The investigators estimate that the average postoperative blood loss is 200ml with a standard deviation of 100ml over 3 days. Based on this assumption. A total number of patients (control + Seamguard groups) of 60 is required if the expected reduction of the mean drainage volume is 100ml and 82 patients for an expected drainage volume reduction of 85ml. All patients candidates to a laparoscopic gastric bypass will be enrolled in the study Under the conditions this is a primary bariatric procedure (no revision allowed)., no history of hiatal surgery such as anti-reflux nor significant upper abdominal surgery. The only associated surgical procedure allowed is the cholecystectomy. Patients' inclusion : Will be done immediately before surgical procedure following acceptance of a written consent. Bleeding from liver or slpeen injury will lead to patient's exclusion. Methods : Surgical procedures are identical for the 2 surgeons of the study (GB and PT) with 30-50ml gastric pouch. Linear. side to side. Antegastric and antecolic gastrojejunal anstomosis . Use of Echelon 60 linear stapler with GOLD cartridges on stomach. Blue to perform the gastrojejunal anastomosis and white on Small bowel. Peroperativeblood loss and need to apply clips or stitches on the gastric staple line are recorded. Operation time and patient information (BMI. Comorbidities) are recorded as well any noticeable or unexpected event. Postoperative blood loss is assessed by at least 1 abdominal closed circuit suction drain left for a minimum of 3 days (removal on postop day 3 at the earliest). In addition hemoglobin and red cell count is performed on postop day 1 and 2. Absence of leakage is confirmed by methylene blue test perop as well as on postop day 1 before resuming fluids and on postop day 2 by a gastrograffin swallow. Drinks and food are resumed according to the standard practice between postop day 1 and postop day 2. Duration of the hospital stay and postoperative course will be documented. Early follow up is clinically done at 1 month postop without any specific radiological or biological examination. Data collection Will be done on a form during and after the procedure BLOOD LOSS : peroperative volume as well as daily drainage output (postop day 1. 2 and 3) as well as the sum of the 3 postop days. Hemoglobin change is recorded on day 1 and 2. Need to leave drain(s) for more than 3 days is recorded. Study completion : Estimated time to complete the study based on the current experience is between 5 and 7 months. Sudy is closed 1 month after the last inclusion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2009

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 5, 2009

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 18, 2009

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
Last Updated

January 5, 2010

Status Verified

January 1, 2010

Enrollment Period

5 months

First QC Date

August 5, 2009

Last Update Submit

January 4, 2010

Conditions

Keywords

Gastric bypassstaple line reinforcementoutcomesper and postoperative blood loss

Outcome Measures

Primary Outcomes (1)

  • Blood loss volume per and postoperatively, additional hemostatic measures peroperatively, hemoglobin levels postoperatively

    3 days postoperatively

Secondary Outcomes (1)

  • gastrojejunal anastomosis leakage rate: clinical and radiological

    postoperative day 2 (gastrograffin swallow)

Study Arms (2)

Standard stapling without reinforcement

ACTIVE COMPARATOR

Standard Echelon 60 linear stapling with GOLD cartridges

Procedure: Roux-en-Y laparoscopic gastric bypass for morbid obesity

Seamguard gastric stapling line reinforcement

ACTIVE COMPARATOR
Procedure: Roux-en-Y laparoscopic gastric bypass for morbid obesity

Interventions

Primary bariatric surgery. Standard laparoscopic procedure with linear stapling divising of the stomach (Echelon 60 stapler, GOLD cartridges) with or with Seamguard reinforcement

Also known as: Gore Seamguard biomaterial staple line reinforcement
Seamguard gastric stapling line reinforcementStandard stapling without reinforcement

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • all primary laparoscopic Roux-en-Y gastric bypasses for morbid obesity

You may not qualify if:

  • additional procedures except cholecystectomy, peroperative bleeding from spleen or liver injury

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique de l'Anjou

Angers, 49044, France

Location

MeSH Terms

Conditions

Progressive Encephalomyelitis with RigidityPostoperative Hemorrhage

Condition Hierarchy (Ancestors)

HemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsPostoperative Complications

Study Officials

  • Philippe A Topart, MD

    Société de Chirurgie Viscérale

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 5, 2009

First Posted

November 18, 2009

Study Start

July 1, 2009

Primary Completion

December 1, 2009

Study Completion

December 1, 2009

Last Updated

January 5, 2010

Record last verified: 2010-01

Locations